Defective NHLRC1 does not ubiquitinate EPM2A (laforin) and PPP1R3C (PTG) (type 2B disease)

Stable Identifier
R-HSA-3797226
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

NHLRC1 (malin) mediates the ubiquitination of EPM2A (laforin) and PPP1R3C (PTG) associated with cytosolic liver- and muscle-form glycogen granules (Gentry et al. 2005). Defects in NHLRC1 (malin) are the cause of the second commonest form of Lafora disease (Roma-Mateo et al. 2012). The two missense mutant forms of NHLRC1 (malin) annotated here are examples of the disease-associated NHLRC1 alleles that have been described (Chan et al. 2003).

Literature References
PubMed ID Title Journal Year
12958597 Mutations in NHLRC1 cause progressive myoclonus epilepsy

Chan, EM, Young, EJ, Ianzano, L, Munteanu, I, Zhao, X, Christopoulos, CC, Avanzini, G, Elia, M, Ackerley, CA, Jovic, NJ, Bohlega, S, Andermann, E, Rouleau, GA, Delgado-Escueta, AV, Minassian, BA, Scherer, SW

Nat. Genet. 2003
15930137 Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin

Gentry, MS, Worby, CA, Dixon, JE

Proc. Natl. Acad. Sci. U.S.A. 2005
22815132 Deciphering the role of malin in the lafora progressive myoclonus epilepsy

Romá-Mateo, C, Sanz, P, Gentry, MS

IUBMB Life 2012
Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
ubiquitin-protein transferase activity of NHLRC1 mutants [cytosol]
Physical Entity
Activity
Normal reaction
Disease
Name Identifier Synonyms
glycogen storage disease 2747 glycogenosis
Authored
Reviewed
Created
Cite Us!